ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

NCI to Seek Concept Approval For Continuing Group Outreach Program; Five CCOP Proposals Reviewed

July 15, 1983

Blochs to Sponsor “Fighting Cancer”

May 9, 1986

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003